Walls, HelenBackholer, KathrynProietto, JosephMcNeil, John J2015-12-102090-0716http://hdl.handle.net/1885/55648Background. Increasing levels of obesity over recent decades have been expected to lead to an epidemic of diabetes and a subsequent reduction in life expectancy, but instead all-cause and cardiovascular-specific mortality rates have decreased steadily inKeywords: acetylsalicylic acid; angiotensin antagonist; hydroxymethylglutaryl coenzyme A reductase inhibitor; cardiovascular mortality; developed country; diabetes mellitus; disability; hypertension; life expectancy; obesity; prevalence; review; senescence201210.1155/2012/1079892016-02-24